Cargando…
Statin Use and In-hospital Mortality in Patients with COVID-19 and Coronary Heart Disease
The worsening progress of coronavirus disease 2019 (COVID-19) is attributed to the proinflammatory state, leading to increased mortality. Statin works with its anti-inflammatory effects and may attenuate the worsening of COVID-19. COVID-19 patients were retrospectively enrolled from two academic hos...
Autores principales: | Shen, Lan, Qiu, Lin, Wang, Li, Huang, Hengye, Liu, Dong, Xiao, Ying, Liu, Yi, Jin, Jingjin, Liu, Xiulan, Wang, Dao Wen, He, Ben, Zhou, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668894/ https://www.ncbi.nlm.nih.gov/pubmed/34903765 http://dx.doi.org/10.1038/s41598-021-02534-2 |
Ejemplares similares
-
The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19
por: Shen, Lan, et al.
Publicado: (2021) -
Initiation of Statins After Hospitalization for Coronary Heart Disease
por: Ye, Xin, et al.
Publicado: (2007) -
Statins for the Primary Prevention of Coronary Heart Disease
por: Li, Min, et al.
Publicado: (2019) -
Effectiveness and safety of combinational therapy compared with intensified statin monotherapy in patients with coronary heart disease
por: Liu, Chenghua, et al.
Publicado: (2018) -
The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it
por: Xiong, Xiaowei, et al.
Publicado: (2015)